Table 3 Treatment on demand in patients with HAE-nlC1-INH
From: Abstracts of 11th C1-inhibitor Deficiency & Angioedema Workshop
|  | Total (32/143 = 22.3%) | HAE-F12 (24/116 = 19.8%) | HAE-Unknown (8/25 = 28%) | |||
|---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Icatibant | 7 | 21.9 | 3 | 12.5 | 4 | 50.0 |
C1-inhibitor | 3 | 9.4 | 1 | 4.2 | 2 | 25.0 |
Tranexamic acid | 25 | 78.1 | 21 | 87.5 | 4 | 50.0 |
Danazol | 1 | 3.1 | 0 | Â | 1 | 12.5 |